Immatics (IMTX) Revenue (2019 - 2025)
Immatics recorded quarterly Revenue of $23.0 million in Q4 2025, up 279.34% quarter-over-quarter from $6.1 million in Q3 2025, and down 34.97% year-over-year from $35.4 million in Q4 2024.
Immatics' Revenue history runs 7 years deep, the most recent figure standing at $23.0 million for Q4 2025.
- In Q4 2025, Revenue fell 34.97% year-over-year to $23.0 million; the TTM figure through Dec 2025 stood at $54.0 million (down 51.6% YoY), while the FY2025 annual figure was $54.5 million, down 67.25% from the prior year.
- Revenue came in at $23.0 million for Q4 2025 at Immatics, up from $6.1 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $115.5 million in Q1 2022 to a low of $5.4 million in Q2 2025.
- A 5-year average of $22.6 million and a median of $18.2 million in 2021 frame the typical range for Revenue.
- Across the five-year window, Revenue soared 1193.39% in 2022 and slumped 90.9% in 2023, its largest moves.
- Immatics' Revenue stood at $18.0 million in 2021, then jumped by 113.49% to $38.4 million in 2022, then tumbled by 55.4% to $17.1 million in 2023, then jumped by 106.48% to $35.4 million in 2024, then tumbled by 34.97% to $23.0 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $23.0 million, $6.1 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 23.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 23.00 Mn |
| Sep 30, 2025 | 6.06 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 19.55 Mn |
| Dec 31, 2024 | 35.37 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Jun 30, 2024 | 20.20 Mn |
| Mar 31, 2024 | 32.88 Mn |
| Dec 31, 2023 | 17.13 Mn |
| Sep 30, 2023 | 6.45 Mn |
| Jun 30, 2023 | 24.34 Mn |
| Mar 31, 2023 | 10.51 Mn |
| Dec 31, 2022 | 38.41 Mn |
| Sep 30, 2022 | 15.18 Mn |
| Jun 30, 2022 | 18.37 Mn |
| Mar 31, 2022 | 115.50 Mn |
| Dec 31, 2021 | 17.99 Mn |
| Sep 30, 2021 | 7.60 Mn |
| Jun 30, 2021 | 6.25 Mn |
| Mar 31, 2021 | 8.93 Mn |
| Dec 31, 2020 | 11.26 Mn |
| Sep 30, 2020 | 9.19 Mn |
| Jun 30, 2020 | 7.60 Mn |
| Mar 31, 2020 | 7.77 Mn |
| Dec 31, 2019 | 4.85 Mn |
| Sep 30, 2019 | 5.63 Mn |
| Jun 30, 2019 | 6.05 Mn |